Prednisolone co-administered with losartan confers renoprotection in patients with IgA nephropathy

Renal Failure

Volumn 29, Issue 4, 2007, Pages 441-446

  Horita, Yoshio ^a,b   Tadokoro, Masato ^b   Taura, Kouichi ^b   Ashida, Ryuichi ^a   Hiu, Mayumi ^a   Taguchi, Takashi ^c   Furusu, Akira ^c   Kohno, Shigeru ^c  

^a NATIONAL HOSPITAL ORGANIZATION NAGASAKI MEDICAL CENTER   (Japan)

^b Nagasaki Municipal Medical Center   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

Author keywords

Angiotensin II receptor blockers; Corticosteroid; Immunoglobulin A; Nephropathy

Indexed keywords

CREATININE; DIPYRIDAMOLE; IMMUNOGLOBULIN A; LOSARTAN; PREDNISOLONE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; MONOTHERAPY; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULONEPHRITIS, IGA; GLUCOCORTICOIDS; HUMANS; KIDNEY; LOSARTAN; MALE; MIDDLE AGED; PREDNISOLONE; PROSPECTIVE STUDIES;

EID: 34248597810     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220701260511     Document Type: Article

References (19)

1. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med. 1987;64:709-727.
2. Kobayashi Y, Tateno S, Hiki Y, Shigematsu H. IgA nephropathy: Prognostic significance of proteinuria and histological alteration. Nephron. 1983;34:146-153.
3. Radford MG Jr, Donardio JV Jr, Bergstralh EJ, Grande JP. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol. 1997;8:199-207.
4. Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin- converting enzyme inhibitor benazepril on the progression of chronic insufficiency. The angiotensin-converting-enzyme inhibition in progressive renal insufficiency study group. N Engl J Med. 1996;334:939-945.
5. Maschio G, Alberti D, Locatelli F, et al. Angiotensin-converting enzyme inhibitors and kidney protection: the AIPRI trial. The ACE inhibition in Progressive Renal Insufficiency (AIPRI) Study Group. J Cardiovasc Pharmacol. 1999;33(Suppl. 1):S16-S20.
6. Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Lancet. 1998;352:1252-1256.
7. Nakao N, Yoshimura A, Morita H, Takada M, Kayano T, Ideura T. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in nondiabetic renal disease (COOPERATE): a randomized controlled trial. Lancet. 2003;361:117-124.
8. Russo D, Minutolo R, Pisani A, et al. Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidney Dis. 2001;38:18-25.
9. Remuzzi A, Perico N, Sangalli F, et al. ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy. Am J Physiol (Renal Physiol 45). 1999;276:F457-F466.
10. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002;347:738-748.
11. Katafuchi R, Ikeda K, Mizumasa T, et al. Controlled, prospective trial of steroid treatment in IgA nephropathy: A limitation of low-dose prednisolone therapy. Am J Kidney Dis. 2003;41:972-983.
12. Lai KN, Lai FM, Ho CP, Chan KW. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: A long-term controlled trial. Clin Nephrol. 1986;26:174-180.
13. Shoji T, Nakanishi I, Suzuki A, et al. Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy. Am J Kidney Dis. 2000;35:194-201.
14. Katafuchi R, Kiyoshi Y, Oh Y, et al. Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol. 1998;49:1-8.
15. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
16. Samuels JA, Strippoli GF, Craig JC, Schena FP, Molony DA. Immunosuppressive treatments for immunoglobulin A nephropathy: a meta-analysis of randomized controlled trials. Nephrology (Carlton). 2004;9:177-185.
17. Pozzi C, Andrulli S, Del Vecchio L, et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004;15:157-163.
18. Barratt J, Feehally J. Treatment of IgA nephropathy. Kidney Int. 2006;69:1934-1938.
19. Kanno Y, Okada H, Saruta T, Suzuki H. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a three-year follow-up. Clin Nephrol. 2000;54:360-365.